Company news
Kintor Pharmaceutical Ltd news in 2023
Kintor Pharmaceutical Ltd's news releases, calls and decks from 2023, newest first.
Kintor Pharmaceutical: Pharma Announces Publication of Phase Ib/II Data from GT90001 and Nivolumab Combination Therapy for Advanced HCC in BMC Medicine
October 27, 2023
Kintor Pharmaceutical: Pharma Announces the Approval of Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China
October 11, 2023
Kintor Pharmaceutical: Pharma Announces 2023 Interim Results and Recent Business Highlights
August 28, 2023
Kintor Pharmaceutical: Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
August 22, 2023
Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
July 20, 2023
Kintor Pharmaceutical: Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US
May 11, 2023
Kintor Pharmaceutical: Pharma Announces Successful Completion of Phase I Clinical Trial of GT1708F for Treatment of Hematologic Malignancies in China
May 8, 2023
Kintor Pharmaceutical: Pharma Announces Completion of Phase I Clinical Trial of GT20029 in the US
April 18, 2023
Kintor Pharmaceutical: Pharma Announces Completion of First Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
April 14, 2023
Kintor Pharmaceutical: Pharma Announces 2022 Annual Results and Recent Business Progress
March 30, 2023
Kintor Pharmaceutical: Pharma Announces Preclinical Data of GT1708F at AACR 2023
March 16, 2023